Health : Medical Research

Sansum Diabetes Research Institute

Dedicated to improving the lives of people impacted by diabetes through research, education, and care.

four stars

91.21

2219 Bath Street Santa Barbara, CA 93105
tel: (805) 682-7838   Web Site
EIN: 95-1684086

Board Leadership
Alexander M. DePaoli
President

CEO
Ellen M. Goodstein, JD, MEd
Executive Director

  Score
(out of 100)
Rating
Overall Score & Rating 91.21 four stars
  Financial 88.24 three stars
  Accountability & Transparency 96.00 four stars
This rating was published 10/01/2019 and includes data from FY2018, the most recent 990 received at that time.

SANSUM DIABETES RESEARCH INSTITUTE (SDRI) has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. With an established world class reputation for innovation in the field of type 1 diabetes, including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to impact this growing epidemic.
We offer ADA accredited nutrition and diabetes self-management education programs. All of our efforts are focused on significantly improving the lives of those impacted by diabetes.

SANSUM DIABETES RESEARCH INSTITUTE (SDRI) has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. With an established world class reputation for innovation in the field of type 1 diabetes, including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to impact this growing epidemic.
We offer ADA accredited nutrition and diabetes self-management education programs. All of our efforts are focused on significantly improving the lives of those impacted by diabetes.

Impact Information

GuideStar is Charity Navigator's trusted partner in sharing information on how this organization seeks impact.  GuideStar has recognized this organization with a Platinum Seal of Transparency for voluntarily and publicly sharing information about how they measure their progress and results.  Learn More about Impact Information.
Reported Results
Showing 3 of 6
Total in 2018
Number of works published from new writers
15
Number of patients who participated in clinical research trials
445
Number of clinical research trials conducted
25
Number of pregnant women who received care at SDRI with diabetes and delivered healthy babies
140
Number of participants enrolled in our pilot studies at SDRI
130
Number of patients who received clinical care for diabetes at SDRI
115
This impact information is current as of September 2019, when it was provided to us by GuideStar. At this time, Impact information published on this organization's page has no effect on its rating per our methodology.

Financial

three stars

88.24

Accountability & Transparency

four stars

96.00

This rating was published 10/01/2019 and includes data from FY2018, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
70.1%
  Administrative Expenses 18.4%
  Fundraising Expenses 11.3%
  Fundraising Efficiency $0.18
  Working Capital Ratio (years) 2.66
  Program Expenses Growth 13.0%
  Liabilities to Assets 3.6%
All data for Financial Performance Metrics calculations was provided by Sansum Diabetes Research Institute on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Sansum Diabetes Research Institute on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $1,517,367
   Federated Campaigns $0
   Membership Dues $0
   Fundraising Events $0
   Related Organizations $0
   Government Grants $0
Total Contributions $1,517,367
   Program Service Revenue $2,199,541
Total Primary Revenue $3,716,908
   Other Revenue $567,954
TOTAL REVENUE $4,284,862
   
EXPENSES  
   Program Expenses $3,395,759
   Administrative Expenses $908,343
   Fundraising Expenses $554,879
TOTAL FUNCTIONAL EXPENSES $4,858,981
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-574,119
   
Net Assets $14,400,471

Charts

Compensation % of Expenses Paid to Title
$159,615 3.28% Ellen Goodstein Executive Director
Other Salaries of Note
$325,665 6.70% David Kerr Director of Research and Innovation
$290,120 5.97% Jordan Pinsker Senior Research Physician
$199,496 4.10% Kristin Castorino Research Physician
$8,938 0.18% Alexander M. DePaoli President

Mission

SANSUM DIABETES RESEARCH INSTITUTE (SDRI) has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. With an established world class reputation for innovation in the field of type 1 diabetes, including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to impact this growing epidemic.
We offer ADA accredited nutrition and diabetes self-management education programs. All of our efforts are focused on significantly improving the lives of those impacted by diabetes.

Highly Rated

Charity Name & State Overall Score Overall Rating
Sansum Diabetes Research Institute (CA) 91.21 four stars
Be The Match Foundation (MN) 89.42 three stars
Foundation for Angelman Syndrome Therapeutics (IL) 89.24 three stars
National Association of Chain Drug Stores Foundation (VA) 86.19 three stars
Arthritis National Research Foundation (CA) 94.34 four stars

Compare These Charities (Highly Rated)

Charity Contact Info

Sansum Diabetes Research Institute
2219 Bath Street
Santa Barbara, CA 93105
tel: (805) 682-7838
fax: (805) 682-3332
EIN: 95-1684086

Visit Web Site

Board Leadership

Alexander M. DePaoli
President

CEO

Ellen M. Goodstein, JD, MEd
Executive Director